EUVIMEDEUVIMED entdecken
Crossref

Fatty Acid‐Based Nanoparticles: The Synergistic Antibacterial Potential of Cefixime Against Drug‐Resistant Bacteria

Muhammad Awais, Shakeel Ijaz, Qandeel Khalid, Farooq Aziz, Fatima Tariq, Aousaf Ahmad, Muhammad Adeel Arshad, Fahim Ullah Khan, Mubashar Rehman

ChemistrySelect · 2026-11 · 11 (42)

DOI: 10.1002/slct.75048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 04.11.2026. Verfasst von Muhammad Awais und 8 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial resistance (AMR), driven largely by indiscriminate antibiotic use, urgently needs attention. Free fatty acids (FFAs) are conserved components of unicellular eukaryotes, yet their use as nanoparticle‐based antibiotic‐sensitizing agents remains unexplored. We formulated myristic acid (C14) and lauric acid (C12) into oleic acid‐stabilized nanostructured lipid carriers (NLCs, MOD and LOD) by hot‐melt micro‐emulsification and loaded them with cefixime (MOD‐C and LOD‐C). Optimized NLCs measured 133–144 nm with zeta potentials of −19 to −25.8 mV. SEM confirmed spherical morphology, and entrapment efficiency exceeded 80%. DSC and FTIR confirmed successful encapsulation and component compatibility, and drug‐loaded particles released cefixime more slowly than a free‐drug suspension. Against five non‐resistant reference strains, E. coli , P. aeruginosa , K. pneumoniae , S. aureus , and B. subtilis , all formulations, blank and drug‐loaded, were active, with cefixime‐loaded NLCs (MIC 16.068–17.046 µg/mL) slightly better than free cefixime (MIC 20 µg/mL). Blank NLCs alone partially restored activity, with MOD against resistant E. coli only and LOD against resistant E. coli and P. aeruginosa , but neither inhibited MRSA. Loading the same carriers with cefixime, however, restored full antibacterial activity against all three resistant strains. These findings show that FFA‐based NLCs not only deliver cefixime but also resensitize otherwise cefixime‐resistant bacteria.

Zitieren

APA

Awais, M., Ijaz, S., Khalid, Q., Aziz, F., Tariq, F., Ahmad, A., Arshad, M. A., Khan, F. U., & Rehman, M. (2026). Fatty Acid‐Based Nanoparticles: The Synergistic Antibacterial Potential of Cefixime Against Drug‐Resistant Bacteria. ChemistrySelect, 11(42). https://doi.org/10.1002/slct.75048

Vancouver

Awais M, Ijaz S, Khalid Q, Aziz F, Tariq F, Ahmad A, et al. Fatty Acid‐Based Nanoparticles: The Synergistic Antibacterial Potential of Cefixime Against Drug‐Resistant Bacteria. ChemistrySelect. 2026;11(42). doi:10.1002/slct.75048

BibTeX
@article{Awais2026,
  author = {Awais, Muhammad and Ijaz, Shakeel and Khalid, Qandeel and Aziz, Farooq and Tariq, Fatima and Ahmad, Aousaf and Arshad, Muhammad Adeel and Khan, Fahim Ullah and Rehman, Mubashar},
  title = {Fatty Acid‐Based Nanoparticles: The Synergistic Antibacterial Potential of Cefixime Against Drug‐Resistant Bacteria},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {42},
  doi = {10.1002/slct.75048}
}
Kostenlos starten →